Structure | Chemical Name | CAS | MF |
|
CLOSTRIDIAL AGAR
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE7,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
ClostridiumBotulinumTypeANeurotoxinHeavyChain(A.A.869-887)
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE2,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
clostebol
|
|
|
|
Clostridium botulinum L toxin
|
|
|
|
Clostridium botulinum LL toxin
|
|
|
|
Clostridium spiroforme iota toxin
|
|
|
|
Clostridium barati F toxin
|
|
|
|
Clostridium novyi alpha-toxin
|
|
|
|
ClostridiumBotulinumTypeENeurotoxin
|
|
|
|
ClostridiumBotulinumTypeEToxoid
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE15,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostebol propionate
|
2162-44-9
|
C22H31ClO3
|
|
ClostridiumBotulinumTypeANeurotoxinComplex
|
|
|
|
ClostridiumBotulinumTypeANeurotoxinLightChain
|
|
|
|
ClostridiumBotulinumTypeBToxoid
|
|
|
|
CLOSTRIDIUMPERFRINGENS,POLYVALENTIV(TYPES14-17),RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostridium botulinum M toxin
|
|
|
|
CLOSTRIDIUM DIFFICILE SELECTIVE SUPPLEMENT
|
|
|
|
Clostridium perfringens delta-toxin
|
|
|
|
Clostridium difficile enterotoxin B receptor
|
|
|
|
CLOSTRIDIUMPERFRINGENS,POLYVALENTIII(TYPES10-13),RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostridium perfringens iota toxin
|
|
|
|
ClostridiumSpecies
|
|
|
|
CLOSTRIDIUMBOTULINUMETOXOID,MABANTI-
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE13,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
ClostridiumBotulinumTypeENeurotoxinComplex
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE17,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostridium difficile cytotoxin B
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE4,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMBOTULINUMDTOXOID,MABANTI-
|
|
|
|
CLOSTRIDIUMPERFRINGENS,POLYVALENTII(TYPES6-9),RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
clostridial aminopeptidase
|
59680-69-2
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE11,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE5,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE12,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE6,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,POLYVALENTI(TYPES1-5),RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
ClostridiumBotulinumTypeAToxoid
|
|
|
|
CLOSTRIPAIN
|
9028-00-6
|
|
|
ClostridiumDifficile(CommonAg)
|
|
|
|
Clostridium perfringens theta-toxin
|
71329-60-7
|
|
|
Clostridium difficile enterotoxin A receptor
|
|
|
|
ClostridiumBotulinumTypeANeurotoxin
|
|
|
|
ClostridiumBotulinumTypeAHemagglutinin33
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE3,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostridium difficile enterotoxin A
|
|
|
|
ClostridiumBotulinumTypeBNeurotoxinComplex
|
|
|
|
clostomicin
|
|
|
|
CLOSTRIDIUM
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE14,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE10,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE8,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
CLOSTRIDIUMBOTULINUMTOXINA,MABANTI-
|
|
|
|
CLOSTRIDIUMPERFRINGENS&949TOXIN:MABANTI-
|
|
|
|
Clostridium perfringens, D
|
68583-14-2
|
|
|
Clostridium perfringens epsilon-toxin
|
|
|
|
4-Chlorotestosterone acetate
|
855-19-6
|
C21H29ClO3
|
|
CLOSTRIDIUMPERFRINGENS,TYPE16,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
Clostridium perfringens beta-toxin
|
|
|
|
CLOSTRIDIUMPERFRINGENS,TYPE9,RABBITANTI-:SLIDEAGGLUTINATION
|
|
|
|
ClostridiumBotulinumTypeDToxoid
|
|
|
|
Clostridium botulinum cryoprotein
|
|
|
|
CLOSTRIDIUMBOTULINUMATOXOID,MABANTI-
|
|
|
|
Clostridium botulinum toxoid
|
|
|
|
Clostridium perfringens alpha-toxin
|
|
|
|
Clostridium butyricum miyairi II588
|
|
|
|
Closures for WISPTM 48-position autosampler vials
|
|
|
|
Closures for 20 mm culture tubes, disposable
|
|
|
|
Closures for Snap Ring vials
|
|
|
|
Closures for 25 mm culture tubes, disposable
|
|
|
|
CLOUDBERRY
|
|
|
|
CLOUDBERRYSEEDS
|
|
|
|
CLOUDYAPPLEJUICE
|
|
|
|
CLOUDIFIER
|
|
|
|
CLOUDBERRYPULP
|
|
|
|
CLOUD POINT, APPROX. VALUE (-10 )
|
|
|
|
CLOUD POINT, APPROX. VALUE (-2 )
|
|
|
|
CLOUD POINT, APPROX. VALUE (-15 )
|
|
|
|
CLOUD POINT, APPROX. VALUE (-20 )
|
|
|
|
CLOUD POINT, APPROX. VALUE (+5 )
|
|
|
|
Methyl 2-(triphenylphosphoranyl)propanoate
|
2689-62-5
|
C22H23O2P
|
|
ClotriMazole IMp. B (EP): 1-[(4-Chlorophenyl)-diphenylMethyl]-1H-iMidazole
|
|
|
|
ClotriMazole iMpurity E (2-chlorophenyl)phenylMethanone (2-chlorobenzophenone)
|
|
|
|
ClotriMazole IMp. F (EP): 1-(TriphenylMethyl)-1H-iMidazole (DeschloroclotriMazole)
|
|
|
|
ClotriMazole IMp. C (EP): 1-Chloro-2-(chlorodi-phenylMethyl)benzene
|
|
|
|
ClotriMazole Related CoMpound A (o-chlorophenyl)diphenylMethanol
|
|
|
|
ClotriMazole IMpurity A
|
23593-71-7
|
C22H17ClN2
|
|
Clotrimazole /2-chlorophenyldiphenylchloromethane
|
|
|
|
CLOTRIMAZOLE, [3H]-
|
|
C22ClN2T17
|
|
CLOTRIMAZOLE IMP. A (PHARMEUROPA): (2-CHLOROPHENYL)DIPHENYLMETHANOL
|
66774-02-5
|
C19H15ClO
|
|
CLOTRIMAZOLE-D5
|
1185076-41-8
|
C22H17ClN2
|
|
Clotrimazole for peak identification
|
|
|
|
Clotrimazole impurity E
|
|
|
|
clotrimazole-hydrocortisone
|
90155-19-4
|
C43H47ClN2O5
|
|
ClotrimazoleBp98
|
|
|
|
Clotrimazole-Bp/Ep/Usp
|
|
|
|
CLOTRIMAZOLE-D5 (PHENYL-D5)
|
|
C22H12ClD5N2
|
|
Clotrimazole
|
23593-75-1
|
C22H17ClN2
|